• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BLOCK DRUG CO., INC. POLIDENT DENTURE CLEANSER TABLETS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BLOCK DRUG CO., INC. POLIDENT DENTURE CLEANSER TABLETS Back to Search Results
Device Problem Human-Device Interface Problem (2949)
Patient Problems Foreign Body In Patient (2687); Cancer (3262)
Event Type  Other  
Event Description
Kidney cancer [renal cancer].Case description: this case was reported by a consumer and described the occurrence of renal cancer in a male patient who received double salt denture cleanser (polident denture cleanser tablets) tablet (batch number unk, expiry date unknown) for product used for unknown indication.Concurrent medical conditions included blind.On an unknown date, the patient started polident denture cleanser tablets.On an unknown date, an unknown time after starting polident denture cleanser tablets, the patient experienced renal cancer (serious criteria gsk medically significant).The action taken with polident denture cleanser tablets was unknown (dechallenge was unknown).On an unknown date, the outcome of the renal cancer was unknown.The reporter considered the renal cancer to be possibly related to polident denture cleanser tablets.Additional information: adverse event information was received on 06 october 2015.A wife that reported years ago her husband had kidney cancer and she was wondering if this was related to the use of the product since her husband did not rinse his dentures carefully enough since he is blind.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POLIDENT DENTURE CLEANSER TABLETS
Type of Device
DENTURE CLEANSER
Manufacturer (Section D)
BLOCK DRUG CO., INC.
memphis TN
Manufacturer (Section G)
GSK
Manufacturer Contact
glaxosmithkline
research triangle park, NC 27709
8888255249
MDR Report Key5180471
MDR Text Key30122723
Report Number1020379-2015-00015
Device Sequence Number1
Product Code EFT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial
Report Date 10/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Initial Date Manufacturer Received 10/06/2015
Initial Date FDA Received10/21/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-